"Lilly CEO Eyes Bigger Deals in Hunt for Pharma’s ‘White Spaces’" - Bloomberg News

Eli Lilly's CEO has expressed intentions to pursue larger acquisitions to explore untapped opportunities in the pharmaceutical sector, referred to as 'white spaces.' The company is focusing on expanding its portfolio through strategic deals to enhance growth. This approach aligns with Lilly's ongoing efforts to innovate and strengthen its market position.